UzanJ,CarbonnelM,PiconneO,AsmarR,AyoubiJM, 2011.Preeclampsia: pathophysiology, diagnosis, and management,Vasc Health Risk Manag 7 467 -74
OsungbadeKO,IgeOK, 2011.Public health perspectives of preeclampsia in developing countries: implication for health system strengthening,J Pregnancy 481095 -
CanM,SancarE,HarmaM,GuvenB,MunganG,AcikgozS., 2011.Inflammatory markers in preeclamptic patients,Clin Chem Lab Med 49 1469 -72
ParkJE,ChenHH,WinerJ,HouckKA,FerraraN., 1994.Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR,J Biol Chem 269 25646 -54
GilleH,KowalskiJ,LiB,Le CouterJ,MoffatB,ZioncheckTF, 2001.Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants,J Biol Chem 276 3222 -30
TakahashiH,ShibuyaM., 2005.The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions,Clin Sci (Lond 109 227 -41
LebrinF,GoumansMJ,JonkerL,CarvalhoRL,ValdimarsdottirG,ThorikayM, 2004.Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction,EMBO J 23 4018 -28
AggarwalPK,ChandelN,JainV,JhaV., 2012.The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia,J Hum Hypertens 26 236 -41
LevineRJ,LamC,QianC,YuKF,MaynardSE,SachsBP, 2006.Soluble endoglin and other circulating antiangiogenic factors in preeclampsia,N Engl J Med 355 992 -1005
PerucciLO,GomesKB,FreitasLG,GodoiLC,AlpoimPN,PinheiroMB, 2014.Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia,PloS One 9 e97632 -
ToporsianM,GrosR,KabirMG,VeraS,GovindarajuK,EidelmanDH, 2005.A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia,Circ Res 96 684 -92
RabajdovaM,DudicR,UrbanP,DudicovaV,UrdzikP,MarekovaM., 2017.Analysis of transcriptional activities of angiogenic biomarkers during intrauterine complications leading to preterm birth,Eur Rev Med Pharmacol Sci 21 1433 -42
AndraweeraPH,DekkerGA,LaurenceJA,RobertsCT, 2012.Placental expression of VEGF family mRNA in adverse pregnancy outcomes,Placenta 33 467 -72
KimSC,ParkMJ,JooBS,JooJK,SuhDS,LeeKS, 2012.Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia,J Obstet Gynaecol Res 38 665 -73
FarinaA,ZucchiniC,SekizawaA,PurwosunuY,de SanctisP,SantarsieroG, 2010.Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks,Am J Obstet Gynecol 203 575 -7
OkazakiS,SekizawaA,PurwosunuY,FarinaA,WibowoN,OkaiT, 2007.Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women,Obstet Gynecol 110 1130 -6
PaivaP,WhiteheadC,SaglamB,PalmerK,Tong S, 2011.Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia,J Clin Endocrinol Metab 96 E1807 -15
RenY,WangH,QinH,YangJ,WangY,JiangS, 2014.Vascular endothelial growth factor expression in peripheral blood of patients with pregnancy induced hypertension syndrome and its clinical significance,Pak J Med Sci 30 634 -7
SekizawaA,PurwosunuY,FarinaA,ShimizuH,NakamuraM,WibowoN, 2010.Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation,BJOG 117 557 -64
ToftJH,LianIA,TarcaAL,ErezO,EspinozaJ,EideIP, 2008.Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies,J Matern Fetal Neonatal Med 21 267 -73
SinghM,OrazulikeNC,AshmoreJ,KonjeJC, 2013.Changes in maternal serum transforming growth factor beta-1 during pregnancy: a cross-sectional study,Biomed Res Int 318464 -
Martinez-FierroML,Garza-VelozI,Carrillo-SanchezK,Martinez-GaytanV,Cortes-FloresR,Ochoa-TorresMA, 2014.Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia,Hypertens Pregnancy 33 191 -203
WangY,ChenQ,ZhaoM,WaltonK,HarrisonC, 2017.Multiple soluble TGF-beta receptors in addition to soluble endoglin are elevated in preeclamptic serum and they synergistically inhibit TGF-beta signaling,J Clin Endocrinol Metab 102 3065 -74
RomeroR,NienJK,EspinozaJ,TodemD,FuW,ChungH, 2008.A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate,J Matern Fetal Neonatal Med 21 9 -23
NishizawaH,OtaS,SuzukiM,KatoT,SekiyaT,KurahashiH, 2011.Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction,Reprod Biol Endocrinol 9 107 -